We are live on ! Find out more
DRIO icon

DarioHealth

14 hedge funds and large institutions have $442K invested in DarioHealth in 2017 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

56% more funds holding

Funds holding: 914 (+5)

45% more capital invested

Capital invested by funds: $305K → $442K (+$137K)

0% more ownership

Funds ownership: 0%0.01% (+0%)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
14
Holders Change
+5
Holders Change %
+55.56%
% of All Funds
0.32%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
Reduced
2
Closed
Calls
Puts
Net Calls
Net Calls Change

DRIO Hedge Fund Activity: Q4 2017 in Review

14 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in DarioHealth (DRIO) for Q4 2017, worth a combined $442K — up 45% from $305K a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new DRIO positions and 0 closed out — a net gain of 5 holders — while 0 added to existing stakes and 2 trimmed.

The largest buyer was Anson Funds Management, opening a new position worth an estimated $178K. The largest seller was Bard Associates, cutting an estimated $26.4K.

  • 14 institutional investors held DarioHealth (DRIO) as of Q4 2017, up from 9 in Q3 2017.
  • Funds reported $442K of DarioHealth stock for Q4 2017, up 45% quarter-over-quarter.
  • 5 funds opened new DarioHealth positions in Q4 2017 and 0 closed out, a net change of +5 holders.
  • The largest DarioHealth buyer in Q4 2017 was Anson Funds Management, an estimated $178K added.
  • The largest DarioHealth seller in Q4 2017 was Bard Associates, an estimated $26.4K sold.

Based on aggregated 13F filings for Q4 2017.